MULLENNIX STEPHEN (COO) sold 1.4% of their position (145.00 shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $3.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/28/2020ACC: 0001209191-20-025893
-145.00
Net shares
Net seller
$3.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
417.00 acquired · 562.00 disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+417.00
Price / share
—
Trade value
—
% of position
4.2%
4/26/2020
9.81K→10.23K
Ordinary Shares
Direct
Shares
−145.00
Price / share
$24.35
Trade value
$3.53K
% of position
1.4%
4/27/2020
10.23K→10.08K
Total
Net shares
+272.00
Net value
-$3.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/26/2020 | M · Option Exercise | +417.00 | — | — | 4.2% | 9.81K | 10.23K |
| Ordinary Shares Direct | 4/27/2020 | S · Sale | −145.00 | $24.35 | $3.53K | 1.4% | 10.23K | 10.08K |
| Total | +272.00 | -$3.53K | ||||||
Derivative Transactions1
Restricted Stock Units (RSUs)
Direct
Converts to
Ordinary Shares
417.00 shares
Shares
−417.00
Strike price
Held after
2.92K
Exercisable
—
4/26/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSUs) Direct | Ordinary Shares417.00 shares | 4/26/2020 | M · Option Exercise | −417.00 | — | 2.92K |